The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.
about
Current perspectives between metabolic syndrome and cancerVascular Complications of Cancer ChemotherapySurveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experienceEnergy balance and metabolism after cancer treatmentTestosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies.Clinical and genetic aspects of testicular germ cell tumours.Ischemic Heart Disease: Special Considerations in Cardio-Oncology.Cisplatin, etoposide and continuous infusion bleomycin in patients with testicular germ cell tumors: efficacy and toxicity data from a retrospective study.Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs.Cardiovascular disease after cancer therapy.Life expectancy of colon, breast, and testicular cancer patients: an analysis of US-SEER population-based data.Exploration of the treatment challenges in men with intellectual difficulties and testicular cancer as seen in Down syndrome: single centre experience.Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors.Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer.Long-term impact of HIV wasting on physical function.Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapseAre Agonistic Autoantibodies against G-Protein Coupled Receptors Involved in the Development of Long-Term Side Effects of Tumor Chemotherapy?Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors.Detection of metabolic syndrome features among childhood cancer survivors: a target to prevent disease.High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation.Treatment-related cardiovascular late effects and exercise training countermeasures in testicular germ cell cancer survivorship.SEOM clinical guidelines for the management of germ cell testicular cancer (2016).Interdisciplinary evidence-based recommendations for the follow-up of testicular germ cell cancer patients.Interdisciplinary evidence-based recommendations for the follow-up of early stage seminomatous testicular germ cell cancer patients.Complications associated with chemotherapy in testicular cancer management.Metabolic syndrome in patients with hematological diseases.Fertility issues in cancer survivorship.Noncancer causes of death in survivors of testicular cancer.The impact of cisplatinum-based chemotherapy on ventricular function and cardiovascular risk factors in female survivors after malignant germ cell cancer.Treatment-related Cardiovascular Toxicity in Long-term Survivors of Testicular Cancer.Testosterone deficiency in testicular cancer survivors - a systematic review and meta-analysis.Cardiovascular disease in cancer survivors.Cancer as a Risk Factor for Cardiovascular Disease.The cancer is over, now what?: Understanding risk, changing outcomes.Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer.A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention).Vitamin D status among long-term survivors of testicular cancer.Cardiovascular Mortality in Testicular Nonseminomatous Germ Cell Tumors: Does Statistical Significance Imply Clinical Significance?Impact of platinum-based chemotherapy on the progression of atherosclerosis.Comment on 'Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'.
P2860
Q26749299-4F0FC223-BF34-49A1-B18F-E7CF59686B3BQ26766269-8289F692-8634-45EE-820D-8C193AB5927AQ26865862-F54DAEF9-F63B-4DB6-899B-FF6E4BE39387Q27015118-6D70CB7A-A2F4-4BF0-ACEC-4866D282533FQ30836337-80048C0C-C5C8-4146-8550-9A4E211FB997Q33347763-DE16B85A-EB70-477D-8375-F800265A1C04Q33441165-63E0811E-2B90-46DE-891E-A87DEF534DD0Q33523653-A7C48148-924A-4DB8-A14C-E82E81EA824AQ34571555-8C7D47AD-D7BC-4EEE-AB08-6460E11A2752Q34604429-73CA5D0C-1A4A-48F9-8349-C5D54B2E6314Q35570816-2EE07649-CAAF-4EF4-8049-53D0D2B9012DQ35678021-5CEB2EFB-25FD-4A47-A928-63FC145861BBQ36207925-448B618B-D133-4F5B-AB99-BBBBB70CA0D3Q36419161-3DD47776-54CC-4F1B-AB28-FE7BC107796FQ36462022-6A7C4FBD-2B1B-46DE-9E8E-F895BB6B22A4Q36740679-17029879-80B5-462F-AE19-B9FA85BFE5B0Q36744349-29F5F0DC-A4C4-4B1C-A53A-4FB42697F2D5Q37003270-B54E2AF8-691D-421B-834E-8DF9A46A98D0Q37004049-ABCE97A6-2577-4332-83B3-E7EB915BAD54Q37066329-9C3298CB-531D-41C4-B0A6-087267EC70E6Q37251177-1134D8FC-6E6C-448C-B3D9-49AEB007DD7CQ37475147-C9F09236-432F-4EDD-863B-4A4967DF4B31Q37846448-521BD518-DEF3-4256-985E-82449AC96461Q37846564-DC7BC261-659C-47C4-AD42-BB132A1AF68FQ37853021-D0E61A39-B5E5-4BA6-A0E7-8796C3E70E27Q38044776-A3016B89-EFED-4B4D-B618-DA906C478802Q38194105-97C3519B-AE7F-41DE-9919-49D25704AFE4Q38463130-8A58B413-E171-4235-B44C-71DFAD08133FQ38611589-37C44E41-0CD8-4982-A0FE-FAA3911B6FF4Q38663385-66430157-7F49-4915-83BA-91D5065E4945Q38786676-A588874E-CF5F-4565-8EC1-663FD2D6EBEEQ39103481-E18F8A63-DD04-4D57-8FA8-05381338674EQ39249961-D6629C72-0EA0-4545-AF07-BC8FDC47053AQ39749166-3D16F5EE-CA96-4C1E-B995-DD228463A071Q39978264-5E70039D-CF25-4CCA-B399-44A238F3B4A4Q40978092-9BA24BD1-F622-47EB-BAAB-365879E62EFFQ41055710-7F675C61-3426-4A9A-B64F-A66B4E7E13C6Q42350172-9CAA63CF-C742-4521-A566-F7E19D314A92Q42822824-F447B085-9F36-4639-961A-FD8F85A4B9F4Q42921920-DC95059C-D699-4DDD-8857-91977062815D
P2860
The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
The metabolic syndrome and dis ...... isseminated testicular cancer.
@en
The metabolic syndrome and dis ...... isseminated testicular cancer.
@nl
type
label
The metabolic syndrome and dis ...... isseminated testicular cancer.
@en
The metabolic syndrome and dis ...... isseminated testicular cancer.
@nl
prefLabel
The metabolic syndrome and dis ...... isseminated testicular cancer.
@en
The metabolic syndrome and dis ...... isseminated testicular cancer.
@nl
P2093
P356
P1476
The metabolic syndrome and dis ...... disseminated testicular cancer
@en
P2093
Andries J Smit
Dirk T Sleijfer
Harald J Hoekstra
Janine Nuver
Wim J Sluiter
P304
P356
10.1200/JCO.2005.02.176
P407
P577
2005-02-28T00:00:00Z